Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
May 12, 2023 at 12:55 PM EDT
Eli Lilly's stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer's disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|